NAMPT Inhibitors Market is driven by oncology applications
NAMPT inhibitors are a class of small-molecule therapeutics targeting nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD+ biosynthesis that supports rapidly proliferating cancer cells. By inhibiting NAMPT, these compounds induce metabolic stress and apoptosis in tumor cells, offering a novel mechanism distinct from traditional chemotherapies. NAMPT Inhibitors Market Advantages...
0 Comments 0 Shares 103 Views 0 Reviews